Dealmaking picked up pace across health care, data, and tech on Tuesday, with a string of announcements showing how companies are choosing to buy growth rather than build it from scratch. From Nvidia's minority stake in a French health care platform to a potential $3.5 billion acquisition by London Stock Exchange Group and a $1.3 billion take-private of dating app Bumble, the message is clear: speed matters.
A flurry of deals across sectors
Nvidia, the chipmaker at the center of the artificial intelligence boom, has taken a minority stake in Doctolib, a French platform that helps patients book appointments and manage health records. The move fits a broader pattern: Nvidia has been pushing its AI technology into health care, where it can help with everything from diagnostics to administrative tasks. Rather than building its own health care software, Nvidia is partnering with an established player.
In a separate health care deal, Agilent, a life-sciences equipment maker, is buying Proscia, a pathology software company, for $240 million in cash, plus up to $30 million more if certain future goals are met. Proscia's software helps pathologists analyze tissue samples, and Agilent says the deal will deepen its AI-enabled diagnostics offering. For Agilent, the acquisition is a way to add software to its hardware business, which could help it sell more complete solutions to labs.
In the financial data world, London Stock Exchange Group (LSEG) confirmed it is in talks with private equity firm Permira to buy Octus, a financial data and analytics company, for about $3.5 billion. Octus provides data and research on private credit and other alternative assets, a fast-growing area of finance. LSEG, which operates the London Stock Exchange and also sells data and analytics, is looking to expand its data business.
And in the consumer tech space, Bumble, the dating app company, has agreed to go private in a deal valued at about $1.3 billion. The buyer is Ithaca Holdings, an investment firm. Bumble has struggled to reignite user growth, and going private will give it room to reset away from the public market's quarterly scrutiny.
Why deals are happening now
The through-line across these deals is speed. Instead of spending years developing new products or entering new markets organically, companies are using acquisitions and partnerships to bolt on capabilities quickly. That's especially true in areas like AI, where the technology is evolving fast and being first can be a big advantage.
For Nvidia, the Doctolib stake is part of a larger push to embed its chips and software into health care workflows. The company has been expanding its AI footprint beyond data centers, and health care is a key target. By partnering with Doctolib, Nvidia gets access to a large user base and real-world health care data, which can help it refine its AI tools.
For LSEG, the Octus deal would be a bet on steadier revenue. Trading activity can swing sharply month to month, so exchanges that rely heavily on transaction fees often see bumpier results. Data and analytics products, by contrast, are typically sold on multi-year contracts that renew, which can smooth revenue and make costs easier to spread as the business grows. If LSEG adds more of that contract-style income through Octus, investors may start judging it less like a volume-sensitive exchange and more like a financial data vendor. That shifts the conversation toward customer retention and margins, and it can support higher valuations than an execution-only business when markets are calm.
The Bumble deal shows a different kind of pressure. The dating app market is crowded, and Bumble has struggled to grow its user base. Going private gives the company more flexibility to invest in product changes or marketing without worrying about quarterly earnings calls. It's a reminder that sometimes the best move for a struggling public company is to leave the public markets.
What it means for investors
For everyday investors, these deals offer a few takeaways. First, M&A activity can be a signal of confidence. When companies are willing to write big checks, it often means they see growth opportunities ahead. That's especially true in health care and data, where AI is creating new possibilities.
Second, the LSEG-Octus talks highlight the value of recurring revenue. Companies that can lock in customers with subscriptions tend to be more stable investments than those that depend on one-off transactions. That's why exchanges and data providers are so keen to expand their data businesses.
Third, the Nvidia-Doctolib deal underscores how AI is moving into every corner of the economy. Health care is one of the most promising areas, and companies that can successfully apply AI to diagnostics or patient care could see big rewards. Health care stocks have been in focus recently, and this deal adds to that momentum.
Finally, the Bumble take-private is a reminder that not every company thrives in the public market. For investors, it's worth watching whether other struggling tech companies follow suit. Deal activity has been heating up across sectors, and more take-privates could be on the way.
As always, no single deal should drive your portfolio decisions. But watching where companies are putting their money can give you a sense of where the market sees growth. And in this case, the money is flowing toward AI, data, and health care—three areas that are likely to stay busy for a while.
